Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Exchange Rate Effect came in at $5.0 million in Q2 2026, down 96.75% year-over-year from $154.0 million in Q2 2025, and up 120.0% quarter-over-quarter from -$25.0 million in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Exchange Rate Effect across 18 years of filings, most recently posting $5.0 million for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 96.75% year-over-year to $5.0 million; the TTM figure through Jun 2026 stood at -$43.0 million (down 129.66% YoY), while the FY2025 annual figure was $201.0 million, up 169.55% from the prior year.
- Exchange Rate Effect came in at $5.0 million for Q2 2026 at Johnson & Johnson, up from -$25.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $154.0 million in Q2 2025 to a low of -$198.0 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is -$24.4 million, with a median of -$10.0 million recorded in 2026.
- Year-over-year, Exchange Rate Effect plunged 546.43% in 2024 and surged 281.18% in 2025.
- Over 5 years, Exchange Rate Effect stood at $16.0 million in 2022, then jumped by 681.25% to $125.0 million in 2023, then plunged by 258.4% to -$198.0 million in 2024, then jumped by 111.62% to $23.0 million in 2025, then tumbled by 78.26% to $5.0 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $5.0 million in Q2 2026, -$25.0 million in Q1 2026, and $23.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 5.00 Mn |
| Mar 29, 2026 | -25.00 Mn |
| Dec 28, 2025 | 23.00 Mn |
| Sep 28, 2025 | -46.00 Mn |
| Jun 29, 2025 | 154.00 Mn |
| Mar 30, 2025 | 70.00 Mn |
| Dec 29, 2024 | -198.00 Mn |
| Sep 29, 2024 | 119.00 Mn |
| Jun 30, 2024 | -85.00 Mn |
| Mar 31, 2024 | -125.00 Mn |
| Dec 31, 2023 | 125.00 Mn |
| Oct 1, 2023 | -168.00 Mn |
| Jul 2, 2023 | -97.00 Mn |
| Apr 2, 2023 | 28.00 Mn |
| Jan 1, 2023 | -187.00 Mn |
| Apr 3, 2022 | 16.00 Mn |
| Oct 3, 2021 | -92.00 Mn |
| Jul 4, 2021 | 45.00 Mn |
| Apr 4, 2021 | -78.00 Mn |
| Jan 3, 2021 | 224.00 Mn |